Nasal Spray Epinephrine Treatment Awaits FDA Approval
The U.S. Food and Drug Administration (FDA) has shocked many by deciding not to approve a pioneering nasal spray as an alternative to current epinephrine autoinjectors, like EpiPens. The announcement was met with surprise, especially from ARS Pharma, the creator of the product named Neffy. The FDA’s move came despite an earlier endorsement in May […]